• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    Digital Therapeutics Market

    ID: MRFR/Pharma/5030-HCR
    100 Pages
    Rahul Gotadki
    September 2025

    Digital Therapeutics Market Research Report By Application (Chronic Disease Management, Mental Health Disorders, Preventive Care, General Wellness), By Delivery Mode (Software, Device, Platform), By End User (Patients, Providers, Payers, Employers), By Therapeutic Area (Diabetes, Cardiology, Neurology, Oncology) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Digital Therapeutics Market Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Digital Therapeutics Market Summary

    As per Market Research Future Analysis, the Digital Therapeutics Market was valued at 6.16 USD Billion in 2023 and is projected to grow to 40 USD Billion by 2035, reflecting a CAGR of 16.88% from 2025 to 2035. The market is driven by the rising prevalence of chronic diseases and mental health issues, alongside increased investment in digital health technologies.

    Key Market Trends & Highlights

    The Digital Therapeutics Market is evolving with significant trends and opportunities.

    • Chronic Disease Management application is expected to grow from 2.5 USD Billion in 2024 to 14.0 USD Billion by 2035.
    • Mental Health Disorders segment is projected to increase from 2.0 USD Billion in 2024 to 10.5 USD Billion by 2035.
    • Investment in digital health startups exceeded 14 Billion USD in 2021, indicating strong market support.
    • North America is expected to dominate the market, growing from 3.5 USD Billion in 2024 to 20.0 USD Billion by 2035.

    Market Size & Forecast

    2023 Market Size USD 6.16 Billion
    2024 Market Size USD 7.2 Billion
    2035 Market Size USD 40 Billion
    CAGR (2025-2035) 16.88%

    Major Players

    Key players include Better Therapeutics, Mindstrong Health, Pear Therapeutics, SilverCloud Health, and Akili Interactive.

    Digital Therapeutics Market Trends

    The Digital Therapeutics Market is changing a lot because more healthcare is becoming digital, there is more focus on customized medication, and healthcare is moving toward prevention. These important commercial forces are pushing for new treatment options that use technology to help people with health problems.

    As chronic illnesses have become more common across the world, healthcare practitioners have started to use digital therapy in addition to conventional ones. Many governments and healthcare organizations promote this acceptance by pushing for the use of digital health technologies to improve patient outcomes.

    The integration of digital therapeutics into healthcare systems appears to enhance patient engagement and improve clinical outcomes, suggesting a transformative shift in the management of chronic diseases.

    U.S. Department of Health and Human Services

    Digital Therapeutics Market Drivers

    Market Growth Projections

    Rising Prevalence of Chronic Diseases

    The Global Digital Therapeutics Market Industry is experiencing growth driven by the increasing prevalence of chronic diseases such as diabetes, cardiovascular disorders, and mental health issues. As healthcare systems worldwide grapple with the burden of these conditions, digital therapeutics offer innovative solutions for disease management and prevention. For instance, the World Health Organization indicates that chronic diseases account for 71 percent of all deaths globally. This alarming statistic underscores the urgent need for effective interventions, positioning digital therapeutics as a viable option. The market is projected to reach 7.2 USD Billion in 2024, reflecting the growing demand for these technologies.

    Increased Investment in Digital Health

    Investment in digital health solutions is a significant driver of the Global Digital Therapeutics Market Industry. Governments and private sectors are increasingly recognizing the potential of digital therapeutics to enhance healthcare delivery and reduce costs. Initiatives such as funding programs and grants are being established to support the development of innovative digital health solutions. For instance, the U.S. government has allocated substantial resources to promote telehealth and digital therapeutics, reflecting a broader commitment to modernizing healthcare. This influx of capital is expected to catalyze market growth, with a compound annual growth rate of 16.87 percent projected from 2025 to 2035.

    Growing Demand for Personalized Medicine

    The shift towards personalized medicine is influencing the Global Digital Therapeutics Market Industry significantly. Patients increasingly seek tailored treatment options that cater to their unique health profiles, and digital therapeutics provide a platform for such customization. By leveraging data analytics and patient feedback, these solutions can adapt to individual needs, enhancing treatment adherence and outcomes. The rise of precision medicine initiatives globally further supports this trend, as healthcare providers aim to deliver more effective interventions. This growing demand is likely to propel the market forward, aligning with the broader healthcare movement towards individualized care.

    Technological Advancements in Healthcare

    Technological advancements play a pivotal role in the expansion of the Global Digital Therapeutics Market Industry. Innovations in artificial intelligence, machine learning, and mobile health applications enhance the efficacy and accessibility of digital therapeutics. For example, AI-driven platforms can analyze patient data to provide personalized treatment plans, improving patient outcomes. The integration of wearable devices further facilitates real-time monitoring and intervention, thereby fostering patient engagement. As these technologies evolve, they are likely to attract more investments, contributing to a projected market growth to 40 USD Billion by 2035, indicating a robust trajectory for digital health solutions.

    Regulatory Support and Reimbursement Policies

    Regulatory support and favorable reimbursement policies are critical factors driving the Global Digital Therapeutics Market Industry. Governments and regulatory bodies are increasingly recognizing the importance of digital therapeutics in enhancing patient care. Initiatives to establish clear guidelines and frameworks for the approval and reimbursement of digital health solutions are being implemented. For instance, the U.S. Food and Drug Administration has introduced pathways for the approval of digital therapeutics, facilitating market entry. As reimbursement policies evolve to include digital therapeutics, the financial viability of these solutions improves, encouraging further adoption and investment in the sector.

    Market Segment Insights

    Digital Therapeutics Market Application Insights

    The Digital Therapeutics Market, particularly in the Application segment, demonstrates a promising trajectory with significant contributions from various applications such as Chronic Disease Management, Mental Health Disorders, Preventive Care, and General Wellness. As of 2024, the market is projected to generate revenue of approximately 7.2 USD Billion, with Chronic Disease Management representing a major contributor, valued at 2.9 USD Billion.

    This segment plays a crucial role as it addresses long-term health conditions, thereby capturing a sizeable share of the market. Looking towards 2035, the valuation for Chronic Disease Management is expected to increase dramatically to 16.0 USD Billion, underscoring its vital position in this industry. Furthermore, Mental Health Disorders follow closely, with a market valuation of 2.0 USD Billion in 2024, anticipated to grow to 11.5 USD Billion by 2035.

    This growth reflects the increasing awareness and focus on mental health, a domain that has gained recognition due to the rising incidence of mental health issues and the effectiveness of digital interventions.

    Get more detailed insights about Digital Therapeutics Market Research Report – Forecast to 2035

    Regional Insights

    The Digital Therapeutics Market shows significant growth across various regions, with North America expected to hold a majority share, valued at 3.2 USD Billion in 2024 and projected to rise to 17.5 USD Billion by 2035. This dominance is driven by advanced healthcare infrastructure and increasing adoption of technology in the region. Europe follows closely, with a valuation of 2.0 USD Billion in 2024, rising to 12.0 USD Billion by 2035, showcasing a strong focus on healthcare innovation.

    Meanwhile, Asia Pacific, valued at 1.5 USD Billion in 2024, offers substantial growth potential due to rising healthcare needs and increasing smartphone penetration, expected to reach 6.5 USD Billion by 2035.

    South America and the Middle East and Africa, valued at 0.5 USD Billion and 0.5 USD Billion in 2024 respectively, indicate emerging markets with significant growth opportunities as digital healthcare solutions gain traction. The combined insights from these regions highlight a robust trajectory within the Digital Therapeutics Market, influenced by technological advancements and increasing health awareness driving market growth.

    Digital Therapeutics Market Regional Insights

    Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

    Key Players and Competitive Insights

    The Digital Therapeutics Market has been experiencing rapid growth, driven by advancements in technology, an increasing prevalence of chronic diseases, and a growing focus on personalized healthcare solutions. This landscape is characterized by a multitude of players who are innovating in areas like software development, medical devices, and data analytics to provide evidence-based, therapeutic interventions through digital platforms. The market is highly competitive, with a blend of established companies and new entrants aiming to leverage digital solutions to enhance patient outcomes and optimize healthcare delivery.

    Key competitive insights reveal that companies within this market are emphasizing significant factors such as regulatory approvals, partnerships for product development, and evidence generation through clinical studies to differentiate their services and secure market foothold.

    Propeller Health has established a significant presence in the Digital Therapeutics Market by focusing on innovative solutions for respiratory health management. The company's strengths lie in its robust digital platform that enables real-time tracking of medication usage and patient adherence, which is essential for asthma and chronic obstructive pulmonary disease management. Propeller Health has gained recognition for its ability to provide actionable insights to healthcare providers and patients, thus improving health outcomes.

    The company has partnered with various healthcare organizations to expand its reach and continuously enhance its platform’s capabilities, underscoring its commitment to transforming chronic disease management through digital therapeutics.

    Key Companies in the Digital Therapeutics Market market include

    Industry Developments

    Recent developments in the Digital Therapeutics Market reflect a dynamic landscape with ongoing innovations and collaborations. Notably, Biofourmis continues to enhance its presence through partnerships aimed at integrating digital therapeutics with traditional healthcare solutions, while Propeller Health has focused on expanding its respiratory disease management applications. In September 2023, Click Therapeutics announced strategic collaborations with major pharmaceutical entities to further develop its digital therapeutics for chronic diseases, enhancing its market position.

    Furthermore, Livongo Health has reported significant growth in its user base, emphasizing the increasing acceptance and utilization of Digital Therapeutics. In terms of mergers and acquisitions, in July 2023, Akili Interactive completed its acquisition of a competitor, boosting its product portfolio. The continued investment in research and development across these companies illustrates a commitment to innovation, underscoring the robust growth in this sector. Major events over the past couple of years include an increasing recognition of digital health solutions by regulatory bodies and advancing reimbursement criteria, paving the way for greater product adoption in various markets globally.

    Future Outlook

    Digital Therapeutics Market Future Outlook

    The Digital Therapeutics Market is projected to grow at a 16.87% CAGR from 2024 to 2035, driven by technological advancements, increasing chronic disease prevalence, and rising demand for personalized healthcare solutions.

    New opportunities lie in:

    • Develop AI-driven therapeutic solutions for chronic disease management. Expand partnerships with healthcare providers to enhance patient engagement. Invest in regulatory compliance strategies to streamline market entry.

    By 2035, the Digital Therapeutics Market is expected to be a pivotal component of global healthcare.

    Market Segmentation

    Digital Therapeutics Market End User Outlook

    • Patients
    • Providers
    • Payers
    • Employers

    Digital Therapeutics Market Regional Outlook

    • North America
    • Europe
    • South America
    • Asia Pacific
    • Middle East and Africa

    Digital Therapeutics Market Application Outlook

    • Chronic Disease Management
    • Mental Health Disorders
    • Preventive Care
    • General Wellness

    Digital Therapeutics Market Delivery Mode Outlook

    • Software
    • Device
    • Platform

    Digital Therapeutics Market Therapeutic Area Outlook

    • Diabetes
    • Cardiology
    • Neurology
    • Oncology

    Report Scope

    Report Attribute/MetricDetails
    Market Size 20236.16(USD Billion)
    Market Size 20247.2(USD Billion)
    Market Size 203540.0(USD Billion)
    Compound Annual Growth Rate (CAGR)16.87% (2025 - 2035)
    Report CoverageRevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year2024
    Market Forecast Period2025 - 2035
    Historical Data2019 - 2024
    Market Forecast UnitsUSD Billion
    Key Companies ProfiledPropeller Health, Biofourmis, Akili Interactive, Better Therapeutics, Pear Therapeutics, Click Therapeutics, Omada Health, Livongo Health, WellDoc,
    Segments CoveredApplication, Delivery Mode, End User, Therapeutic Area, Regional
    Key Market OpportunitiesTelehealth integration expansion, Chronic disease management solutions, Increased investment in R&D, Growing demand for personalized therapies, Rise in healthcare data analytics
    Key Market Dynamicsrising chronic disease prevalence, increasing demand for remote healthcare, advancements in mobile technology, growing investment in healthcare innovation, regulatory support for digital solutions
    Countries CoveredNorth America, Europe, APAC, South America, MEA



     

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment

    FAQs

    What is the expected market size of the Digital Therapeutics Market by 2024?

    The Digital Therapeutics Market is expected to be valued at 7.2 billion USD by the year 2024.

    What is the projected market size of the Digital Therapeutics Market by 2035?

    By 2035, the Digital Therapeutics Market is anticipated to reach a valuation of 40.0 billion USD.

    What is the expected CAGR for the Digital Therapeutics Market from 2025 to 2035?

    The market is projected to exhibit a compound annual growth rate (CAGR) of 16.87% from 2025 to 2035.

    Which region is expected to hold the largest market share for Digital Therapeutics by 2035?

    North America is anticipated to hold the largest market share, valued at 17.5 billion USD by 2035.

    What will be the market size for Chronic Disease Management in 2035?

    The market size for Chronic Disease Management is expected to reach 16.0 billion USD by 2035.

    What is the expected market size for Mental Health Disorders by 2035?

    The market for Mental Health Disorders is projected to be valued at 11.5 billion USD by 2035.

    Who are the key players in the Digital Therapeutics Market?

    Major players in the market include Propeller Health, Biofourmis, Akili Interactive, and Pear Therapeutics among others.

    What is the projected market size for Preventive Care by 2035?

    The Preventive Care segment is expected to reach a market size of 6.5 billion USD by 2035.

    What is the expected market size for Europe in 2035?

    The European market is projected to be valued at 12.0 billion USD by 2035.

    What opportunities and challenges are anticipated in the Digital Therapeutics Market?

    The market anticipates opportunities in emerging technologies while facing challenges related to regulatory approvals and integration with existing healthcare systems.

    Digital Therapeutics Market Research Report – Forecast to 2035 Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Stories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study
    Chemicals and Materials